Mode
Text Size
Log in / Sign up

ICOPE screening tool shows preliminary feasibility for older adults but requires standardized implementation pathsNew screening tool shows promise for older adults with cognitive issues

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that ICOPE screening feasibility depends on cultural context and lacks evidence for long-term effects.

This scoping review synthesizes evidence regarding the implementation, integration paths, and influencing factors of the ICOPE screening tool for older adults. The scope includes an evaluation of design, population reach, positive screening rates, and psychometric properties across various cultural backgrounds.

The authors note that while the ICOPE framework shows preliminary feasibility and global acceptance, performance is highly dependent on specific cultural and population contexts. Results indicate that positive screening rates vary significantly due to differences in research design and assessment criteria. Psychometric properties were also found to differ across various cultural backgrounds.

Several implementation challenges are highlighted, including a disconnection between screening and intervention, uneven accessibility of digital tools, and the absence of unified diagnostic criteria. Furthermore, there is a noted lack of evidence regarding long-term effects. These factors suggest that while the tool is feasible, its practical application requires more standardized pathways to ensure consistent results.

Clinical utility is currently limited by these inconsistencies. The review suggests that while ICOPE is a recognized framework, practitioners should be aware that performance varies significantly and long-term outcomes are not yet established.

Finding the right way to support aging parents or neighbors is often difficult because many tools do not work well across different cultures. A global look at the ICOPE screening tool shows it is gaining acceptance as a way to find potential issues early, but its success depends heavily on how it is used in specific communities.

The review found that while the tool is useful, the number of people it identifies with positive results varies greatly depending on who is being tested and what criteria are used. Because the tool must work for diverse groups, researchers noted that its performance can change based on a person's cultural background.

There are still hurdles to clear before this becomes a standard. Some challenges include a lack of unified rules for diagnosis and uneven access to digital tools. While the tool shows it is feasible to use globally, we still need more evidence on how it works over the long term to ensure it provides lasting support.

What this means for you:
The ICOPE tool is a promising way to screen older adults, but its success depends on local context and culture.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundWith the rapid global population aging, systematically and early identifying and managing functional decline in older adults has become a core challenge in public health. The Integrated Care for Older People (ICOPE) framework and its screening tool, proposed by the World Health Organization (WHO), aim to prevent disability by assessing intrinsic capacity. However, there is a lack of systematic review of the implementation strategies, effects, and challenges of this tool in different global contexts. This study aimed to review the global implementation evidence of the ICOPE screening tool, analyze its integration paths and influencing factors, and provide a basis for constructing an integrated care model suitable for different resource environments.MethodsThis study systematically retrieved and included literatures meeting the criteria, and comprehensively sorted and conducted comparative analyses of the design, population, positive screening rate, tool performance indicators (such as sensitivity and specificity), and implementation challenges of the included studies.ResultsThe study demonstrated significant heterogeneity in the global application of the ICOPE screening tool. The positive screening rates vary greatly due to differences in research design, target populations, and assessment criteria. The psychometric properties of the tool differ across various cultural backgrounds, and the implementation process faces common challenges such as disconnection between screening and intervention, uneven accessibility of digital tools, lack of evidence for long-term effects, and absence of unified diagnostic criteria.ConclusionThe ICOPE framework shows preliminary feasibility and global acceptance, but the performance of the screening tools needs to be interpreted in the context of specific cultures and populations. Future research should focus on unifying core measurement indicators, conducting long-term validity verification, and establishing a standardized implementation path integrating screening, assessment, and intervention to promote effective implementation of this strategy globally, especially in resource-limited areas.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.